News LCT investigates possible prevention of Type 1 diabetes Living Cell Technologies (ASX:LCT)
announced today that early stage research of its NeurotrophinCell
(NtCell) product may hold the potential to prevent or delay the
onset of Type I diabetes. Related Document |